Status:
COMPLETED
Isolation and Characterization of Mammary Stem Cells
Lead Sponsor:
National Cancer Institute (NCI)
Collaborating Sponsors:
National Institutes of Health (NIH)
Conditions:
Stem Cells
Eligibility:
All Genders
Brief Summary
Background: * Cancer stem cells in breast cancer have been identified as a small population of tumor cells whose self-renewal mechanism is highly deregulated. This deregulation seems to be necessary ...
Detailed Description
Cancers are composed of heterogeneous populations of cells with varying degrees of proliferative capacity and ability to reconstitute tumors when transplanted into nude or SCID mice. Recently, cancer...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- The tissue samples will come from the human cooperative network. They have their own set of criteria. We are requesting tissue samples from individuals that are normal as well as those who have cancer.
- EXCLUSION CRITERIA:
- The tissue samples will come from the human cooperative tissue network and we are asking for normal samples from individuals who don't have any opportunistic diseases.
Exclusion
Key Trial Info
Start Date :
April 7 2006
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 23 2011
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT00340392
Start Date
April 7 2006
End Date
March 23 2011
Last Update
July 2 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cancer Institute (NCI), 9000 Rockville Pike
Bethesda, Maryland, United States, 20892